Vision

TONY REID, M.D. Ph.D.
Chief Executive Officer

Dr. Tony Reid, Chief Executive Officer at EpicentRx, holds a PhD focused in Antiviral and Antitumor Activity from Stanford. Reid further pursued his MD at Stanford focusing on targeted viral vector for cancer therapy and histone deacetylase inhibitors. In addition to his role at EpicentRx, Reid continues his 13 years as a Professor of Medicine at the University of California San Diego Moores Cancer Center as a medical oncologist focused on early phase clinical research while simultaneously developing an adenoviral platform. Dr. Reid holds numerous national awards such as America’s Top Doctor (top 1%), 2008 to present, America’s Top Doctor for Cancer (top 1%), 2009 to present, and America’s Most Honored Professional (top 1%), 2016 to present.

FRANCK BRINKHAUS, Ph.D.
Chief Financial Officer

Dr. Brinkhaus serves as EpicentRx Chief Financial Officer and has experience in strategic advice, corporate finance and capital raising for life science companies. He is CEO & Founder of Biotech Alliances International, Inc., a Silicon Valley-based life sciences investment bank. Previously, Dr. Brinkhaus was Managing Director of Palo Alto-based Woodside Capital Partners. He holds a Master’s degree and a Ph.D. in Economics.

RICHARD GORDON, M.D. Ph.D., DABT
Chief Neuroscience Collaborator

Dr Richard Gordon leads the Translational Neuroscience Laboratory at The University of Queensland and has a career track record of research in neuroinflammation. His research program aims to develop new therapeutic strategies for the treatment Parkinson’s disease and other neurodegenerative disorders, with a focus on targeting chronic immune and inflammasome activation which drives neurodegeneration. Dr Gordon’s research has contributed to groundbreaking advances in the field neuroinflammation, including most recently, the discovery inflammasome activation in PD as a key driver of synuclein pathology and disease progression. He also Dr Gordon is a board-certified Toxicologist with the American Board of Toxicology (ABT). He is also a Science Ambassador for the World Parkinson’s Coalition and has served on the Gene Technology Technical Advisory Committee (GTTAC) for the Department of Health for the Australian Federal Government.

Dr. Bryan Oronsky serves as EpicentRx Chief Development Officer and combines firsthand clinical experience as a physician with 17 years of pharmaceutical development experience.

CHRIS LARSON, M.D. Ph.D.
Vice President of Viral Therapy

Chris Larson completed an MD/PhD program at UT Southwestern in 2009 with a dissertation in molecular biophysics. Thereafter he completed a residency in Internal Medicine and a fellowship in Hematology/Oncology at UC San Diego where he worked in the lab of Dr. Tony Reid on oncolytic viruses (OVs). Chris was hired by EpicentRx in 2017 when the company acquired the OV technology.

At EpicentRx, his work focuses on the clinical translation of AdAPT-001 and the development of in-house manufacturing processes.

MEAGHAN STIRN, M.B.A.
Controller & VP of Special Projects

Leads financial reporting, accounting, and related internal controls. Since joining in 2015, Mrs. Stirn has served various roles in clinical, corporate, and financial operations. Mrs. Stirn has over 15 years of experience in clinical research management, specializing in oncology and immunology. BA in Chemistry and a BS in Physiological Sciences from the University of Arizona and earned a MBA in Accounting from National University.

SCOTT CAROEN
Sr. Director of Operations & Corporate Development

10 years experience in Clinical Program Development and Life Science Business Strategies. Responsible for Global Operations, working directly with the Executive Team and helps to drive business development by prioritizing opportunities, conducting diligence, and transacting business and collaboration opportunities. Mr. Caroen is a co-author on over 40 peer reviewed scientific publications and co-inventor on 3 pending patents.

RAJAN KUMAR
General Counsel

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque vehicula bibendum neque ut pharetra. Vivamus vel pharetra urna. Nullam viverra sit amet sapien dapibus viverra. Aliquam erat volutpat. Integer diam ipsum, vehicula ac ante ac, ornare eleifend dui. Etiam molestie magna ipsum, dapibus consequat sapien rhoncus eget. Donec vitae augue vitae nibh accumsan aliquam. Sed tempus laoreet vestibulum. In vitae aliquam diam. Etiam nisi purus, egestas in finibus eget, lobortis at elit. Aliquam porttitor dictum risus, quis ornare magna finibus at. Proin sed maximus sem. In vulputate velit nisl, non fermentum ante euismod id.

ALLISON PRATT, MBA, SPHR-CA

Human Resources

I’ve been an HR professional for more than 30 years. About half of that experience was in large corporations, some with more than 2500 employees and some with only four employees. My most recent corporate experience was Vice-President of Human Resources and Administration for Toshiba. During this time, I also spent about 12 years providing as needed human resources consulting services to companies across a wide range of industries. I have a B.S. in Business Administration from California State University, Pomona and an MBA from the University of Phoenix. In 2001, I earned a certificate in Life Coaching from the Hudson Institute of Santa Barbara. Currently, in addition to teaching at up to six different campuses and running my private consulting practice, I speak to groups on various HR and employment related topics such as employee retention and avoiding sexual harassment and litigation.

ELENA PROKOPENKO
VP, Quality

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque vehicula bibendum neque ut pharetra. Vivamus vel pharetra urna. Nullam viverra sit amet sapien dapibus viverra. Aliquam erat volutpat. Integer diam ipsum, vehicula ac ante ac, ornare eleifend dui. Etiam molestie magna ipsum, dapibus consequat sapien rhoncus eget. Donec vitae augue vitae nibh accumsan aliquam. Sed tempus laoreet vestibulum. In vitae aliquam diam. Etiam nisi purus, egestas in finibus eget, lobortis at elit. Aliquam porttitor dictum risus, quis ornare magna finibus at. Proin sed maximus sem. In vulputate velit nisl, non fermentum ante euismod id.